Legal notice

Last updated 28 September 2026

Company

Zentara Inc., a Delaware corporation. Contact: info@zentara.com.

Not medical advice

Everything on this site describes research and investigational concepts. It is not medical advice and must not be used to diagnose, treat or prevent any condition. Speak to a qualified clinician about your health.

ZNT-GLP1 is an investigational, GLP-1–based therapy. It is not approved by any regulatory authority, and its safety and effectiveness have not been established.

Illustrative models

Charts marked "Schematic", "Illustrative" or "Illustrative model" explain concepts. They do not show clinical data, trial results or predictions for any individual.

AD Prevention Bonds

AD Prevention Bonds are a proposed framework; nothing on this site is an offer to sell or a solicitation to buy securities. Any target yields or terms shown are illustrative parameters of the proposed framework, not promises of return.

Forward-looking statements

This site contains forward-looking statements about Zentara's plans, research, potential therapies, financial structures and expected outcomes. Words such as "aim", "plan", "target", "could" and "heading toward" identify them. They reflect current expectations and involve risks and uncertainties, including scientific, clinical, regulatory, financial and market risks, so actual results may differ materially. Zentara undertakes no obligation to update them.

Sources

Figures on this site come from the Zentara thesis (E. Nourzai, 2 February 2025). Estimates are approximate.

Intellectual property and credits

No warranty

The site is provided as is, without warranties of any kind. To the extent permitted by law, Zentara is not liable for any loss arising from its use.